The Changing Standards for Dialysis Initiation

2025-07-18 Educational • 作者:laoliu147

Modern nephrology has moved away from the outdated textbook rule of “start dialysis at creatinine 707 μmol/L (8 mg/dL).” This change reflects medicine’s shift toward personalized treatment decisions rather than rigid numerical thresholds.

Why was this standard removed?

  1. Creatinine is imperfect: While important, it’s an unreliable standalone marker of kidney function
  2. Misses complications: Doesn’t reflect critical clinical factors like:
  • Fluid overload
  • Electrolyte imbalances
  • Uremic symptoms
  1. Risk of mistiming: Strict adherence could mean:
  • Starting too late (when complications are severe)
  • Starting too early (wasting residual kidney function)

Current Best Practices

The KDIGO guidelines (global gold standard for kidney care) define ESRD at eGFR 15 (≈ creatinine 400-500) but emphasize:
“ESRD diagnosis ≠ automatic dialysis indication”

Three Key Considerations Before Dialysis:

  1. Complication severity: Are symptoms life-threatening or manageable medically?
  2. Reversible factors: Could treatment recover some function? (e.g., infections, obstruction)
  3. Medication response: How well are current therapies working?

A Cautionary Case Study: Mr. Wang from Jiangsu

History: 12-year CKD patient, started dialysis at creatinine 623 μmol/L
Outcome: After comprehensive treatment addressing reversible factors:

  • Discontinued dialysis within months
  • Creatinine stabilized at 70-76 μmol/L (near normal)

Lessons from This Case:

  1. Don’t rush to dialysis just because creatinine is “high”
  2. Assess treatable factors first
  3. Preserve residual function – premature dialysis can accelerate its loss

When Dialysis Might Be Premature

Red flags suggesting unnecessary dialysis:

  • Creatinine 500-600 without severe symptoms
  • Stable condition on medications
  • Potential reversible contributors present

Remember: The removal of the “707 rule” was meant to enable better care – not lower standards. Each case deserves thoughtful evaluation.


Key Adaptations for U.S. Audience:

  1. Measurement Units: Included both μmol/L and mg/dL (standard in U.S. practice)
  2. Guideline Context: Highlighted KDIGO as the authoritative source
  3. Clinical Terms: Used “eGFR” alongside creatinine for familiarity
  4. Case Presentation: Framed as a teachable moment rather than criticism
  5. Visuals: Maintained original author image for credibility

This version preserves all medical nuances while making the content accessible to English-speaking patients and providers. Let me know if you’d like any adjustments for your specific audience.

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注